tradingkey.logo

Boehringer Ingelheim, Cue Biopharma Partner To Develop Autoimmune And Inflammatory Disease Treatments

ReutersApr 14, 2025 9:34 PM

- Cue Biopharma Inc CUE.O:

  • BOEHRINGER INGELHEIM AND CUE BIOPHARMA PARTNER TO DEVELOP TREATMENT FOR AUTOIMMUNE AND INFLAMMATORY DISEASES

  • CUE BIOPHARMA INC: UNDER COLLABORATION, CO TO RECEIVE UP-FRONT PAYMENT OF $12 MILLION AS WELL AS RESEARCH SUPPORT PAYMENTS

  • CUE BIOPHARMA INC: CO IS ALSO ELIGIBLE TO EARN UP TO ABOUT $345 MILLION IN MILESTONE-BASED PAYMENTS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI